FTXH: First Trust Nasdaq Pharmaceuticals ETF
Performance
Watchlist
Select an item
Summary
FTXH at a glance
FTXH returned +36.07% over the past year and +11.71% a year over five years. Its worst drop in that year was -7.47%, smaller than 71% of ETFs on Redstone, and its Sharpe ratio of 1.58 beats 97% of ETFs on Redstone. It yields 0.67%.
Current Drawdown
-4.07%
Rolling Volatility
20.53%
Dividends
FTXH dividends
Yield
0.67%
Paid, past year
$0.29
Pays
Quarterly
Growth a year
+15.1%
Per share, by year
Yearly return over 5 years
FTXH paid $0.29 a share over the past year, every quarter. Its yearly rate rose from $0.30 in 2022 to $0.46 in 2025, 15.1% a year. With dividends reinvested it returned +11.71% a year over five years, against +10.19% on price alone.
›All 20 payments since Dec 23, 2021
- Sep 24, 2026$0.0113
- Jun 25, 2026$0.092
- Mar 26, 2026$0.0573
- Dec 12, 2025$0.1294
- Sep 25, 2025$0.1453
- Jun 26, 2025$0.0892
- Mar 27, 2025$0.0992
- Dec 13, 2024$0.1304
- Sep 26, 2024$0.1218
- Jun 27, 2024$0.1284
- Mar 21, 2024$0.0676
- Dec 22, 2023$0.1232
- Sep 22, 2023$0.0725
- Jun 27, 2023$0.1179
- Mar 24, 2023$0.1001
- Dec 23, 2022$0.1253
- Sep 23, 2022$0.0911
- Jun 24, 2022$0.0384
- Mar 25, 2022$0.0488
- Dec 23, 2021$0.1101
Metrics
Risk Indicators
Profile
About FTXH
The First Trust Nasdaq Pharmaceuticals ETF seeks investment results that correspond generally to the price and yield (before the Fund’s fees and expenses) of an equity index called the Nasdaq US Smart Pharmaceuticals Index.
From its prospectus, filed Aug 3, 2026- Category
- Health Care
- Expense ratio
- 0.60%
- Fund size
- $1.2B
- Inception
- Sep 2016
Rankings
Lists FTXH is on
Comparisons